How many months does Fenelidone (Keshenda) start to take effect and treatment planning suggestions?

Finerenone (Finerenone) is a selective nonsteroidal mineral corticoid receptor antagonist (MRA). It is mainly used in patients with chronic kidney disease (CKD) combined with type 2 diabetes to slow down the deterioration of renal function and reduce the risk of cardiovascular events. Its mechanism of action is to inhibit the excessive activation of mineralocorticoid receptors and reduce fibrosis and inflammatory responses in the kidneys and cardiovascular system, thereby delaying the progression of the disease.

In clinical studies, the efficacy of fenelidone usually begins to appear after 2 to 3 months of use. The main manifestations are the slowdown in the increase in serum creatinine, the decrease in urinary albumin/creatinine ratio (UACR), and the slight improvement in blood pressure. Regarding cardiovascular protection, it may also take longer to observe significant effects, but most patients can feel the stable trend of renal function indicators after continuous treatment for 3 to 6 months.

In terms of treatment planning, fenelidone is usually taken orally once a day, and the dose is adjusted individually based on the patient's renal function and blood potassium level. Serum potassium and renal function markers need to be assessed before starting treatment to ensure safety. During the course of treatment, serum potassium and creatinine should be rechecked every 4 weeks or so, and the dose should be adjusted or the drug temporarily discontinued if necessary, especially in patients who are combined with diuretics, ACEI or ARB , and strict monitoring is required.

Long-term treatment is recommended to be based on continuous treatment and individualized management under the guidance of a doctor. Most patients can take fenelidone long-term at a stable dose to maintain renoprotective and cardiovascular preventive effects. At the same time, lifestyle intervention, blood pressure and blood sugar management should be combined to comprehensively improve the efficacy. Through scientific treatment planning and regular monitoring, fenelidone can achieve sustained renal and cardiovascular benefits in a safe and controllable manner.

Reference link:https://www.drugs.com